Cover Image

A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

Abstract Background To assess the efficacy and safety of a combination therapy involving fimasartan, amlodipine, and rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond to fimasartan monotherapy. Methods This phase III, randomized, double-blind, multicenter stud...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eun-Seok Jeon (Author), Sang Wook Lim (Author), Seok-Yeon Kim (Author), Hyoung-Mo Yang (Author), Moo Hyun Kim (Author), Moo-Yong Rhee (Author), Seung Hwan Han (Author), Jinho Shin (Author), Kwang-il Kim (Author), Jin-Ok Jeong (Author), Ki Chul Sung (Author), Geu Ru Hong (Author), Hyung-Seop Kim (Author), Kihwan Kwon (Author), Tae-Soo Kang (Author), Hae-Young Lee (Author), Su-Eun Han (Author)
Format:	Book
Published:	BMC, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
by: Rhee MY, et al.
Published: (2015)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
by: Kang WY, et al.
Published: (2018)

Evaluation of stability and simultaneous determination of fimasartan and amlodipine by a HPLC method in combination tablets
by: Hyeon Woo Moon, et al.
Published: (2014)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
by: Oh M, et al.
Published: (2018)

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians
by: Lee J, et al.
Published: (2018)

The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan
by: Gu N, et al.
Published: (2016)

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension
by: Shin MS, et al.
Published: (2016)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
by: Huijin Lee, et al.
Published: (2024)

Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved In Situ Absorption Method in Rats
by: Tae Hwan Kim, et al.
Published: (2018)

Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study
by: Kim S, et al.
Published: (2014)

Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
by: Choi Y, et al.
Published: (2018)

The Ameliorative Effect of Fimasartan against Methotrexate-Induced Nephrotoxicity in Rats
by: Maryam Rasheed Abd, et al.
Published: (2022)

Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice
by: Jong-Ho Kim, et al.
Published: (2019)

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
by: Kang WY, et al.
Published: (2020)

Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial
by: Sungjoon Park, MD, et al.
Published: (2024)

Effect of home blood pressure monitoring for blood pressure control in hypertensive patients taking multiple antihypertensive medications including fimasartan (the FORTE study)
by: Jung-Yeon Choi, et al.
Published: (2020)

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
by: Yoon DY, et al.
Published: (2020)

Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational Study
by: Oh GC, et al.
Published: (2020)

Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial
by: Dong Hoon Shin, et al.
Published: (2019)

Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)
by: Dong Joo Oh, et al.
Published: (2018)

Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)
by: Chung WB, et al.
Published: (2020)

Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II
by: Radhika G. Sojitra, et al.
Published: (2021)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
by: Oh M, et al.
Published: (2019)

The Effects of Obesity and Physical Activity on Dyslipidemia in Persons With Type 2 Diabetes
by: Yun-A Shin, et al.
Published: (2022)

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
by: Ihm SH, et al.
Published: (2016)

Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
by: Moon SJ, et al.
Published: (2019)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
by: Chilbert MR, et al.
Published: (2022)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020)

Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants
by: Jin-Woo Park, et al.
Published: (2024)

Clinical efficacy and safety of lamotrigine monotherapy in newly diagnosed pediatric patients with epilepsy
by: Ji Hye Han, et al.
Published: (2010)

Clinical and diagnostic importance of dyslipidemia in children and adolescents during the coronavirus disease 2019 pandemic
by: Eun Young Kim
Published: (2022)

Pharmacokinetic Interactions Between the Fixed-Dose Combination of Ezetimibe/Rosuvastatin 10/20 Mg and the Fixed-Dose Combination of Telmisartan/Amlodipine 80/5 Mg in Healthy Subjects
by: Ryu H, et al.
Published: (2024)

Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
by: Yasufumi Seki, et al.
Published: (2023)

Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease
by: Hyo Jin Kang, et al.
Published: (2013)

Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review
by: S. R. Gilyarevsky, et al.
Published: (2022)

Simultaneous estimation of rosuvastatin and amlodipine in pharmaceutical formulations using stability indicating HPLC method
by: Muhammad Ashfaq, et al.
Published: (2014)

Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study
by: Bong-Joon Kim, et al.
Published: (2022)

EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015)

USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
by: O. M. Drapkina, et al.
Published: (2017)

EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015)